Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Zeno Ashai to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- City of Hope Medical Group Inc, Pasadena, California, 91105
- City of Hope, Duarte, California, 91010
- City of Hope Medical Center, Duarte, California, 91010
- City of Hope Comprehensive Cancer Center, Duarte, California, 91010
-
Washington
- University of Washington Medical Center, Seattle, Washington, 98195
-
Texas
- M D Anderson Cancer Center, Houston, Texas, 77030
-
Wisconsin
- University of Wisconsin Hospital and Clinics, Madison, Wisconsin, 53792
-
Illinois
- NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, 60201
- University of Chicago, Chicago, Illinois, 60637
- University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637
-
Indiana
- Indiana University Medical Center, Indianapolis, Indiana, 46202
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202
Powered by
SC CTSI